Gold Looks for 7th Straight Weekly Gain
Gold prices held steady on Friday and were poised for a seventh consecutive weekly gain as U.S. President Donald Trump’s plans to impose reciprocal tariffs on every country taxing U.S. imports fueled concerns of a global trade war.Spot gold held its ground at $2,929.05 U.S. per ounce, early Friday morning. Bullion hit a record peak of $2,942.70 on Tuesday.U.S. gold futures rose 0.4% to $2,957.40.On Thursday, Trump tasked his economics team with devising plans for reciprocal tariffs on every country taxing U.S. imports, and the targets include China, Japan, South Korea and the European Union.A major trigger for gold prices this week was Trump’s announcement to impose reciprocal tariffs, which is creating tariff war concerns and could impact global economies. Meanwhile, data on Thursday showed the U.S. producer price index (PPI) saw a strong increase in January, following Wednesday’s inflation report that revealed consumer prices had risen at the fastest pace in nearly a year and a half.The PPI data offered more evidence that inflation was accelerating again and strengthened views that the Federal Reserve would not cut interest rates before the second-half of the year.Bullion is traditionally viewed as a safe haven against inflation and economic uncertainty, but the appeal of this non-yielding asset diminishes with rising interest rates.Spot silver gained 0.4% to $32.50 U.S. per ounce. Platinum was up 0.3% at $997.65 U.S. and palladium rose 0.6% to $999.77 U.S.. All three metals were set for a weekly gain.
Recent Posts

Romanian Inflation Ends Tumultuous Year in Politics Close to 10%

UK Boosts Support For Offshore Wind in Bumper Auction

Ireland Is Trying to Get Back on the Data Center Bandwagon

Notice Concerning Change of Representative Executive Officer

Polish Recycler Bets Millions on Europe’s Critical Metals Push

Blistering Metals Rally Sends Silver, Tin and Copper to Records

Wellington Management Appoints Alex Behm to Strengthen Secondaries Capabilities

TCS and AMD Announce Strategic Collaboration to Drive AI Adoption at Scale

New data reinforces Ipsen’s commitment to bringing solutions and addressing care gaps in neurological diseases at TOXINS

TOXINS 2026: Clinical Updates on Galderma’s Leading Neuromodulator Portfolio Further Reinforce Its Leadership in Injectable Aesthetics


